Pharmacokinetics

Pharmacokinetics

Pharmacokinetics (PK) is the branch of pharmacology concerned with what the body does to a drug, as opposed to pharmacodynamics, which describes what the drug does to the body. PK is commonly described by the ADME framework: absorption (how the drug enters the bloodstream), distribution (how it spreads through body compartments), metabolism (how it is chemically transformed), and excretion (how it is eliminated). These processes collectively determine the concentration of active drug at its target sites over time.

For injectable peptide therapeutics like retatrutide, absorption occurs from the subcutaneous injection site into the systemic circulation. The rate and extent of absorption influence the time to peak plasma concentration (Tmax) and bioavailability. Distribution is affected by protein binding, particularly albumin binding, which is enhanced in retatrutide through fatty acid acylation of the peptide chain. Metabolism of peptide drugs primarily occurs through general proteolytic degradation rather than hepatic cytochrome P450 enzymes, which reduces the risk of drug-drug interactions. Excretion occurs through renal and proteolytic pathways.

Pharmacokinetic data are essential for determining appropriate dosing regimens. For retatrutide, PK studies established the approximately six-day half-life that supports weekly dosing and informed the dose-escalation schedules used in Phase 2 and Phase 3 clinical trials. PK modeling also helps predict drug exposure in special populations, such as patients with renal or hepatic impairment.